€
Gunes- et al.
JOCArticle
3H); 13C NMR (50 MHz, CDCl3) δ 211.1, 141.0, 122.9, 121.0,
50.7, 38.8, 38.6, 35.33, 27.6, 21.1, 15.5; HRMS (ESI) [M þ Hþ]
calcd for 178.1232 (C11H16NO), found 178.1226.
5.2 Hz, 1H), 2.61-2.53 (m, 2H), 2.35 (dd, J = 13.9, 7.9 Hz, 1H),
2.15 (m, 1H), 1.96-1.87 (m, 3H), 1.78-1.58 (m, 2H), 1.38-1.20
(m, 8H), 0.87 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
205.3, 137.7, 121.1, 120.4, 55.3, 41.2, 40.2, 35.3, 32.7 31.5, 29.1,
29.0, 26.0, 24.7, 22.7, 14.2; HRMS (ESI) [M þ Hþ] calcd for
248.2014 (C16H26NO), found 248.2010.
(E)-1-(Hept-2-enyl)-2-oxocyclopentanecarbonitrile (4e). The
general procedure was employed in THF with 100.0 mg (0.78
mmol) of 5a to give 107 mg (65%) of 4e: IR (neat) 2235, 1753
cm-1; 1H NMR (400 MHz, CDCl3) δ 5.71 (dtt, J = 15.4, 6.6, 1.5
Hz, 1H), 5.38 (dtt, J = 15.4, 6.6, 1.5 Hz, 1H), 2.54 (m, 10H),
1.40-1.24 (m, 4H), 0.87 (t, J = 7.1 Hz, 3H); 13C NMR (100
MHz, CDCl3) δ 209.5, 137.8, 122.0, 119.3, 48.9, 37.0, 36.8, 33.5,
32.4, 31.5, 22.4, 19.4, 14.1; HRMS (ESI) [M þ Hþ] calcd for
206.1545 (C13H20NO), found 206.1539.
(þ)-(E)-1-(4-Hydroxybut-2-enyl)-2-oxocyclopentanecarbonitrile
(4l). The general procedure was employed in THF with 72.0 mg
(0.56 mmol) of 5a to give 133 mg (55%) of 4l. The enantiomeric
ratio was determined on the alcohol derived by deprotecting 4l
(260 mg, 0.62 mmol) with Bu4NF, which afforded alcohol i (39.0
mg, 35%). 93:7 er was determined by HPLC (Daicel OB-H, 10%
isopropanol/hexanes, 0.9 mL/min 207 nm, tR (major) = 40.9 min,
(þ)-(E)-1-(Oct-2-enyl)-2-oxocyclopentanecarbonitrile (4f). The
general procedure was employed in THF with 200.0 mg (1.57
mmol) of 5a to give 192 mg (65%) of 4f: 95:5 er was determined by
HPLC (Daicel AS, 5% isopropanol/hexanes, 1.0 mL/min 295 nm,
tR (major) = 9.7 min, tR (minor) = 8.6 min). [R]25D = þ30.15 (c
tR (minor) = 32.9 min). [R]20 = þ16.77 (c 1.55, CHCl3); IR
D
1
(neat) 3411, 2238, 1751 cm-1; H NMR (200 MHz, CDCl3) δ
5.82-5.51 (m, 2H), 4.04 (dd, J = 4.9, 1.1 Hz, 2H), 2.66-1.88 (m,
8H); 13C NMR (50 MHz, CDCl3) δ210.9, 137.7, 125.2, 120.8, 64.4,
50.5, 38.4, 35.5, 21.0; HRMS (ESI) [M þ Hþ] calcd for 180.1025
(C10H14NO2), found 180.1019.
1.26, ethyl acetate); IR (neat) 2236, 1755 cm-1; H NMR (400
1
MHz, CDCl3) δ 5.63 (dt, J = 15.2, 7.3 Hz, 1H), 5.38 (dt, J = 15.2,
7.4 Hz, 1H), 2.55 (dd, J = 14.2, 7.2 Hz, 1H), 2.50-2.29 (m, 3H),
2.25 (dd, J = 14.2, 8.0 Hz, 1H), 2.16-1.93 (m, 5H), 1.40-1.20 (m,
6H), 0.88 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
209.4, 137.8, 122.0, 119.2, 49.0, 37.1, 37.0, 33.5, 32.7, 31.5, 29.0,
22.7, 19.4, 14.3; HRMS (ESI) [M þ Hþ] calcd for 220.1701
(C14H22NO), found 220.1696.
(E)-2-Oxo-1-(5-phenylpent-2-enyl)cyclopentanecarbonitrile (4g).
The general procedure was employed in THF with 200.0 mg (1.57
mmol) of 5a to give 119 mg (60%) of 4g: IR (neat) 2234, 1753
cm-1; 1H NMR (200 MHz, CDCl3) δ 7.33-7.16 (m, 5H), 5.65 (dt,
J = 15.3, 6.3 Hz, 1H), 5.45-5.31 (dt, J = 15.3, 7.3 Hz, 1H), 2.72 (t,
J = 7.5 Hz, 2H) 2.60-1.87 (m, 10H); 13C NMR (50 MHz, CDCl3)
δ 210.0, 142.4, 137.3, 129.5, 129.3, 126.9, 123.8, 120.0, 49.5, 37.7,
37.6, 36.4, 35.1, 34.1, 20.1; HRMS (ESI) [M þ Hþ] calcd for
254.1545 (C17H20NO), found 254.1539.
1-(Cyclohex-2-enyl)-2-oxocyclopentanecarbonitriles (4h). The
general procedure was employed in THF with 200.0 mg (1.57
mmol) of 5a to give 350 mg (60%) of 4h. Careful chromatogra-
phy gave two pure fractions of the first and second eluting
isomers (85 mg and 45 mg, respectively). First isomer: light
yellow oily liquid, Rf = 0.3 (1:9 EtOAc/hexanes). IR (neat)
2233, 1755 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.91-5.88 (m,
1H), 5.13 (d, J = 10.4 Hz, 1H), 2.87-2.4 (m, 1H), 2.59-2.52 (m,
1H), 2.37-1.97 (m, 8H), 1.87-1.82 (m, 1H), 1.60-1.39 (m, 2H);
13C NMR (100 MHz, CDCl3) δ 209.9, 133.0, 124.3, 119.0, 52.9,
39.5, 38.1, 31.1, 26.0, 25.1, 21.6, 19.8. Second isomer: colorless
liquid, Rf = 0.23 (1:9 EtOAc/hexanes). IR (neat) 2234, 1750
cm-1; 1H NMR (400 MHz, CDCl3) δ 5.97-5.92 (m, 1H), 5.81
(d, J = 12.0 Hz, 1H), 2.70-2.65 (m, 1H), 2.55-2.49 (m, 1H),
2.37-2.25 (m, 2H), 2.18-1.98 (m, 5H), 1.89-1.72 (m, 2H),
1.58-1.47 (m, 1H), 1.37-1.23 (m, 1H); 13C NMR (100 MHz,
CDCl3) δ 209.4, 131.8, 125.2, 119.1, 52.4, 39.4, 37.7, 31.6, 24.9,
24.7, 22.8, 19.5; HRMS (ESI) [M þ Naþ] calcd for 212.1051
(C12H15NaNO), found 212.1046.
(-)-(E)-2-Oxo-1-(4-phenylbut-2-enyl)cyclopentanecarbonitrile
(4m). The general procedure was employed in THF with 167.0
mg (1.30 mmol) of 5a to give 151 mg (48%) of 4m: 95:5 er was
determined by HPLC (Daicel OB-H, 20% isopropanol/hexanes,
1.0 mL/min 210 nm, tR (major) = 17.8 min, tR (minor) = 22.4
min); [R]20 = -10.4 (c 0.58; EtOAc); IR (neat) 2236, 1751
D
cm-1 1H NMR (400 MHz, CDCl3) δ 7.33-7.29 (m, 2H),
;
7.23-7.17 (m, 3H), 5.81 (dtt, J = 15.0, 6.8, 1.1 Hz, 1H), 5.53
(dddt, J = 15.0, 8.1, 6.8, 1.4 Hz, 1H), 3.41 (d, J = 6.8 Hz, 2H),
2.62-2.26 (m, 5H), 2.14-1.93 (m, 3H); 13C NMR (100 MHz,
CDCl3) δ 209.4, 140.0, 136.0, 128.8, 128.7, 126.5, 123.8, 119.2,
48.8, 39.2, 37.0, 36.8, 33.7, 19.4; HRMS (ESI) [M þ Hþ] calcd for
240.1388 (C16H18NO), found 240.1383.
(þ)-2-Oxo-1-(2-oxo-4-phenylbutyl)cyclopentanecarbonitrile (4n).
The general procedure was employed in THF with 210.0 mg (1.64
mmol) of 5a to give 350 mg (72%) of 4n. The enantiomeric ratio was
determined on the corresponding ketone obtained by hydrolysis
with 2 M HCl which afforded quantitatively ii (301.0 mg). 90:10 er
was determined by HPLC (Daicel OC, 10% isopropanol/hexanes,
1.0 mL/min 206 nm, tR (major) = 72.6 min, tR (minor) = 66.2
min). [R]20D = þ2.8 (c 2.86; EtOAc); IR (neat) 2230, 1755, 1716
cm-1; 1H NMR (400 MHz, CDCl3) δ 7.30-7.13 (m, 5H), 3.09 (s,
2H), 2.87 (t, J = 7.5 Hz, 2H), 2.74 (t, J = 7.5 Hz, 2H), 2.65-2.40
(m, 3H), 2.17-2.04 (m, 3H); 13CNMR (100 MHz, CDCl3) δ208.8,
204.8, 140.3, 128.9, 128.5, 126.6, 118.6, 46.2, 45.1, 44.1, 36.7, 33.7,
29.8, 20.1; HRMS (ESI) [M þ Hþ] calcd for 256.1338 (C16H18-
NO2), found 256.1332.
(S)-(-)-1-((S)-2-Bromocyclohex-2-enyl)-2-oxocyclopentane-
carbonitrile (4o). The general procedure was employed in THF
with 69.0 mg (0.54 mmol) of 5a to give 79 mg (55%) of 4o:
[R]20 = -124 (c 1.00; CHCl3); IR (KBr) 2229, 1745 cm-1
;
D
1H NMR (400 MHz, CDCl3) δ 6.34-6.32 (m, 1H), 3.22-
3.16 (m, 1H), 2.63-2.52 (m, 2H), 2.32 (m, 1H), 2.20-2.02
(m, 5H), 1.93 (m, 1H), 1.80 (m, 1H), 1.56 (m, 1H), 1.37 (m,
1H); 13C NMR (100 MHz, CDCl3) δ 208.7, 136.3, 120.7,
119.6, 52.2, 45.3, 38.6, 31.5, 27.7, 27.2, 20.4,19.6; HRMS
(ESI) [M þ Hþ] calcd for 268.0337 (C12H15BrNO), found
268.0332.
1-(2-Methylallyl)-2-oxocyclohexanecarbonitrile (4j). The gen-
eral procedure was employed in hexanes with 100.0 mg (0.71
mmol) of 5b to give 88 mg (70%) of 4j: IR (neat) 2218, 1730
1
cm-1; H NMR (400 MHz, CDCl3) δ 4.98 (m, 1H), 4.85 (m,
1H), 2.84 (ddd, J = 13.7, 11.1, 5.7 Hz, 1H), 2.75 (d, J = 14.3
Hz, 1H), 2.49 (m, 1H), 2.38-2.32 (m, 2H), 2.13-1.98 (m, 2H),
1.93-1.66 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 202.9,
139.3, 120.2, 116.6, 50.3, 40.9, 39.0, 38.1, 28.4, 23.5, 21.9;
HRMS (ESI) [M þ Hþ] calcd for 178.1232 (C11H16NO), found
178.1220.
(þ)-(E)-1-(Oct-2-enyl)-2-oxocycloheptanecarbonitrile (4k). The
general procedure was employed in hexanes with 185.0 mg (1.19
mmol) of 5c to give 191 mg (65%) of 4k: [R]20D = þ13 (c 1.00;
CHCl3); IR (neat) 2239, 1715 cm-1; 1H NMR (400 MHz, CDCl3)
δ 5.60 (dt, J = 14.9, 6.8 Hz, 1H), 5.37 (m, 1H), 2.69 (dt, J = 12.5,
(þ)-1-((5S)-2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-enyl)-2-
oxocyclopentanecarbonitrile (4p). The general procedure was
employed in THF with 160.0 mg (1.26 mmol) of 5a to give 224
mg (73%) of 4p. The diastereomers were carefully separated to
obtain pure first and second eluting isomers for characteriza-
tion. First isomer: 1H NMR (400 MHz, CDCl3) δ 5.68 (m, 1H),
4.75 (m, 1H), 4.70 (m, 1H), 3.08 (m, 1H), 2.66-1.80 (m, 10H),
1.74 (s, 3H), 1.40 (s, 3H). Second isomer: IR (neat) 2229, 1755
1
cm-1; H NMR (400 MHz, CDCl3) δ 5.68 (m, 1H), 4.76 (s,
1H), 4.67 (s, 1H), 2.67 (m, 1H), 2.55 (m, 1H), 2.39-2.00 (m,
11H), 1.86 (s, 3H), 1.70 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
J. Org. Chem. Vol. 75, No. 21, 2010 7097